A century later, still fighting back: antigen-specific immunotherapies for type 1 diabetes

Autor: Rodriguez-Fernandez, S, Almenara-Fuentes, L, Perna-Barrull, D, Barneda, B, Vives-Pi, M

Publikováno v: Immunology and Cell Biology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Type 1 diabetes (T1D) is a chronic metabolic disease caused by the autoimmune destruction of insulin-producing beta-cells. Ever since the 1920s, the fate of patients suffering from T1D was dramatically improved owing to the isolation and production o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::2ec143c454b87bc7a1991d56f812acdf
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2423

A century later, still fighting back: antigen-specific immunotherapies for type 1 diabetes.

Autor: Rodriguez-Fernandez S; Immunology Section, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain.; Ahead Therapeutics SL, Barcelona, Spain., Almenara-Fuentes L; Immunology Section, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain.; Ahead Therapeutics SL, Barcelona, Spain., Perna-Barrull D; Immunology Section, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain., Barneda B; Ahead Therapeutics SL, Barcelona, Spain., Vives-Pi M; Immunology Section, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain.; Ahead Therapeutics SL, Barcelona, Spain.

Publikováno v: Immunology and cell biology [Immunol Cell Biol] 2021 May; Vol. 99 (5), pp. 461-474. Date of Electronic Publication: 2021 Feb 11.